| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/11/2012 | CA2661042C Agents for blood-brain barrier delivery |
| 12/11/2012 | CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 12/11/2012 | CA2606348C Anti-il-6 antibodies, compositions, methods and uses |
| 12/11/2012 | CA2586803C Purification of immunoglobulins |
| 12/11/2012 | CA2549467C A preventive agent for vasculitis |
| 12/11/2012 | CA2540848C Method for stabilizing antibody and stabilized solution-type antibody preparation |
| 12/11/2012 | CA2524534C Methods and compositions for the prevention and treatment of sepsis |
| 12/11/2012 | CA2494008C Anti-myelin associated glycoprotein (mag) antibodies |
| 12/11/2012 | CA2481479C Novel flavivirus antigens |
| 12/11/2012 | CA2202519C Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase |
| 12/09/2012 | CA2779710A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 12/06/2012 | WO2012167181A1 Lysyl oxidase-like 2 assay and methods of use thereof |
| 12/06/2012 | WO2012167143A1 Antibodies specific for tgf-beta |
| 12/06/2012 | WO2012167039A1 Fc RECEPTOR BINDING PROTEINS |
| 12/06/2012 | WO2012166287A1 Method of treating vision disorders |
| 12/06/2012 | WO2012165926A2 Marker for diagnosing liver cancer containing anti-atic autoantibody, and composition for diagnosing liver cancer containing antigen thereof |
| 12/06/2012 | WO2012165925A2 Anti-c-met antibody having hgf activity and use thereof |
| 12/06/2012 | WO2012164372A1 Recombinant anti-canine parvovirus antibody and uses thereof |
| 12/06/2012 | WO2012164320A1 Biological system for the production of specifically biotinylated monoclonal antibodies |
| 12/06/2012 | WO2012164063A1 Humanised anti-cd52 antibodies |
| 12/06/2012 | WO2012164034A1 Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders |
| 12/06/2012 | WO2012164021A1 Il-21 epitope and il-21 ligands |
| 12/06/2012 | WO2012164004A1 Novel antigen peptide and uses thereof |
| 12/06/2012 | WO2012163932A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use |
| 12/06/2012 | WO2012163887A1 Inhibition of bone resorption with rankl binding peptides |
| 12/06/2012 | WO2012163807A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection |
| 12/06/2012 | WO2012163805A1 Bcma (cd269/tnfrsf17) -binding proteins |
| 12/06/2012 | WO2012163771A1 Magea3 binding antibodies |
| 12/06/2012 | WO2012163769A1 Magea3 binding antibodies |
| 12/06/2012 | WO2012163765A1 Means and methods for diagnosing and treating multiple sclerosis |
| 12/06/2012 | WO2012163544A1 Removal of soluble tumor necrosis factor receptor 2 (stnfr2) |
| 12/06/2012 | WO2012163521A1 Removal of monomeric targets |
| 12/06/2012 | WO2012163520A1 Dual targeting |
| 12/06/2012 | WO2012163519A1 Antibodies with improved folding stability |
| 12/06/2012 | WO2012142515A3 Fc fusion proteins comprising novel linkers or arrangements |
| 12/06/2012 | WO2012112013A3 A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer |
| 12/06/2012 | WO2012092376A3 Comprehensive monoclonal antibody generation |
| 12/06/2012 | WO2011117582A9 Dendritic cell inhibitory proteins from ticks |
| 12/06/2012 | US20120309943 Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier |
| 12/06/2012 | US20120309942 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 12/06/2012 | US20120309941 Immunoglobulin constant region fc receptor binding agents |
| 12/06/2012 | US20120309936 Reducing the immunogenicity of fusion proteins |
| 12/06/2012 | US20120309054 Products Comprising Inactivated Yeasts or Moulds and Active VHH-Type Antibodies |
| 12/06/2012 | US20120309041 Determination of Exosomel Biomarkers for Predicting Cardiovascular Events |
| 12/06/2012 | US20120308598 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins |
| 12/06/2012 | US20120308584 Protein-active agent conjugates and method for preparing the same |
| 12/06/2012 | US20120308582 Molecules and methods for modulating tmem16a activities |
| 12/06/2012 | US20120308580 Hepatitus b virus specific antibody and usese thereof |
| 12/06/2012 | US20120308576 Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands |
| 12/06/2012 | US20120308575 Full human anti-tnf-alpha monoclonal antibody, preparation method and use thereof |
| 12/06/2012 | US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
| 12/06/2012 | US20120308573 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 12/06/2012 | US20120308572 Protofibril-Binding Antibodies and Their Use in Therapeutic and Diagnostic Methods for Parkinson's Disease, Dementia with Lewy Bodies and Other Alpha-Synucleinopathies |
| 12/06/2012 | US20120308571 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody |
| 12/06/2012 | US20120308570 Methods for treating diseases |
| 12/06/2012 | US20120308555 Methods and reagents for creating monoclonal antibodies |
| 12/06/2012 | US20120308514 Human antibodies that bind human il-12 and methods for producing |
| 12/06/2012 | US20120308481 Radio-opaque compounds, compositions containing same and methods of their synthesis and use |
| 12/06/2012 | US20120308478 Antibodies specific for claudin 6 (cldn6) |
| 12/06/2012 | CA2853383A1 Dual targeting |
| 12/06/2012 | CA2837965A1 Humanised anti-cd52 antibodies |
| 12/06/2012 | CA2837736A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use |
| 12/06/2012 | CA2837556A1 Antibodies specific for tgf-beta |
| 12/06/2012 | CA2837534A1 Lysyl oxidase-like 2 assay and methods of use thereof |
| 12/06/2012 | CA2837527A1 Fc receptor binding proteins |
| 12/06/2012 | CA2837518A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection |
| 12/06/2012 | CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies |
| 12/06/2012 | CA2836947A1 Anti-emr1 antibodies |
| 12/06/2012 | CA2835340A1 Inhibition of bone resorption with rankl binding peptides |
| 12/06/2012 | CA2834373A1 Method of treating vision disorders |
| 12/06/2012 | CA2833820A1 Bcma (cd269/tnfrsf17) -binding proteins |
| 12/06/2012 | CA2832391A1 Means and methods for diagnosing and treating multiple sclerosis |
| 12/05/2012 | EP2530143A1 Method for the identification and purification of human naturally occurring regulatory t cells (ntregs) |
| 12/05/2012 | EP2530092A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
| 12/05/2012 | EP2530091A1 Anti-dll3 antibody |
| 12/05/2012 | EP2530090A2 Anti-IL-13R alpha 1 antibodies and their uses thereof |
| 12/05/2012 | EP2530089A1 Neutralising prolactin receptor antibody Mat3 and its therapeutical use |
| 12/05/2012 | EP2530088A1 Means and methods for diagnosing and treating multiple sclerosis |
| 12/05/2012 | EP2530087A2 Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof |
| 12/05/2012 | EP2529758A2 Vitamin receptor binding drug delivery conjugates |
| 12/05/2012 | EP2529754A1 Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide |
| 12/05/2012 | EP2529753A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 12/05/2012 | EP2529752A1 Use for production of therapeutic agent or prophylactic agent for osteoarthritis |
| 12/05/2012 | EP2529751A1 Injectable solution containing therapeutic agent for osteoarthritis |
| 12/05/2012 | EP2528949A1 Antibodies that inhibit metalloproteins |
| 12/05/2012 | EP2528948A2 Novel lowered affinity antibodies and methods of marking the same |
| 12/05/2012 | EP2528947A2 Cd127 binding proteins |
| 12/05/2012 | EP2528946A1 Methods of treating autoimmune diseases with dll4 antagonists |
| 12/05/2012 | EP2528945A2 Methods of treating diabetes with dll4 antagonists |
| 12/05/2012 | EP2528944A1 Rodent combinatorial antibody libraries |
| 12/05/2012 | EP2528939A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 12/05/2012 | EP2528624A1 Extracellular ifi16 as therapeutic agents |
| 12/05/2012 | CN102812047A Anti-C4.4a Antibodies And Uses Thereof |
| 12/05/2012 | CN102812046A CD127 binding proteins |
| 12/05/2012 | CN102812045A Material And Methods For Treating Or Preventing HER-3 Associated Diseases |
| 12/05/2012 | CN102812044A WNT-binding agents and uses thereof |
| 12/05/2012 | CN102812043A Method For Producing T Cell Receptor-like Monoclonal Antibodies And Uses Thereof |
| 12/05/2012 | CN102812042A Process for obtaining antibodies |
| 12/05/2012 | CN102812041A Compositions and Methods for Treatment of Ovarian Cancer |
| 12/05/2012 | CN102812040A SORF Constructs And Multiple Gene Expression |